Literature DB >> 24252615

Ribosome biogenesis in skeletal development and the pathogenesis of skeletal disorders.

Paul A Trainor1, Amy E Merrill2.   

Abstract

The skeleton affords a framework and structural support for vertebrates, while also facilitating movement, protecting vital organs, and providing a reservoir of minerals and cells for immune system and vascular homeostasis. The mechanical and biological functions of the skeleton are inextricably linked to the size and shape of individual bones, the diversity of which is dependent in part upon differential growth and proliferation. Perturbation of bone development, growth and proliferation, can result in congenital skeletal anomalies, which affect approximately 1 in 3000 live births [1]. Ribosome biogenesis is integral to all cell growth and proliferation through its roles in translating mRNAs and building proteins. Disruption of any steps in the process of ribosome biogenesis can lead to congenital disorders termed ribosomopathies. In this review, we discuss the role of ribosome biogenesis in skeletal development and in the pathogenesis of congenital skeletal anomalies. This article is part of a Special Issue entitled: Role of the Nucleolus in Human Disease.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cartilage hair hypoplasia; Ribosome biogenesis; Roberts syndrome; Shwachman–Diamond syndrome; Skeletal development; Treacher Collins syndrome

Mesh:

Substances:

Year:  2013        PMID: 24252615      PMCID: PMC4020712          DOI: 10.1016/j.bbadis.2013.11.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  136 in total

1.  A new paradigm for the regulation of the mammalian ribosomal RNA genes.

Authors:  T Moss; V Stefanovsky; F Langlois; T Gagnon-Kugler
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

2.  Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2.

Authors:  Daniel W Young; Mohammad Q Hassan; Xiao-Qing Yang; Mario Galindo; Amjad Javed; Sayyed K Zaidi; Paul Furcinitti; David Lapointe; Martin Montecino; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

3.  Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.

Authors:  D Pospisilova; J Cmejlova; J Hak; T Adam; R Cmejla
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

4.  Ribosome biogenesis is sensed at the Start cell cycle checkpoint.

Authors:  Kara A Bernstein; Franziska Bleichert; James M Bean; Frederick R Cross; Susan J Baserga
Journal:  Mol Biol Cell       Date:  2006-12-27       Impact factor: 4.138

Review 5.  Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions.

Authors:  Mikael S Lindström; Chad Deisenroth; Yanping Zhang
Journal:  Cell Cycle       Date:  2007-02-18       Impact factor: 4.534

6.  MEF2C transcription factor controls chondrocyte hypertrophy and bone development.

Authors:  Michael A Arnold; Yuri Kim; Michael P Czubryt; Dillon Phan; John McAnally; Xiaoxia Qi; John M Shelton; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Dev Cell       Date:  2007-03       Impact factor: 12.270

7.  Translational efficiency in patients with Diamond-Blackfan anemia.

Authors:  Jana Cmejlova; Ludmila Dolezalova; Dagmar Pospisilova; Kvetoslava Petrtylova; Jiri Petrak; Radek Cmejla
Journal:  Haematologica       Date:  2006-11       Impact factor: 9.941

8.  The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast.

Authors:  Tobias F Menne; Beatriz Goyenechea; Nuria Sánchez-Puig; Chi C Wong; Louise M Tonkin; Philip J Ancliff; Renée L Brost; Michael Costanzo; Charles Boone; Alan J Warren
Journal:  Nat Genet       Date:  2007-03-11       Impact factor: 38.330

9.  Structural and evolutionary bioinformatics of the SPOUT superfamily of methyltransferases.

Authors:  Karolina L Tkaczuk; Stanislaw Dunin-Horkawicz; Elzbieta Purta; Janusz M Bujnicki
Journal:  BMC Bioinformatics       Date:  2007-03-05       Impact factor: 3.169

10.  Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.

Authors:  Jill Dixon; Natalie C Jones; Lisa L Sandell; Sachintha M Jayasinghe; Jennifer Crane; Jean-Philippe Rey; Michael J Dixon; Paul A Trainor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

View more
  42 in total

Review 1.  Paradigms of ribosome synthesis: Lessons learned from ribosomal proteins.

Authors:  Michael Gamalinda; John L Woolford
Journal:  Translation (Austin)       Date:  2015-02-02

2.  Nucleolar Enrichment of Brain Proteins with Critical Roles in Human Neurodevelopment.

Authors:  Lukasz P Slomnicki; Agata Malinowska; Michal Kistowski; Antoni Palusinski; Jing-Juan Zheng; Mari Sepp; Tonis Timmusk; Michal Dadlez; Michal Hetman
Journal:  Mol Cell Proteomics       Date:  2016-04-06       Impact factor: 5.911

3.  An evolutionarily conserved element in initiator tRNAs prompts ultimate steps in ribosome maturation.

Authors:  Sunil Shetty; Umesh Varshney
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

4.  Up-regulation of small nucleolar RNA 78 is correlated with aggressive phenotype and poor prognosis of hepatocellular carcinoma.

Authors:  Pei Ma; Haitao Wang; Lu Han; Wei Jing; Xin Zhou; Zhisu Liu
Journal:  Tumour Biol       Date:  2016-10-21

5.  An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis.

Authors:  Marian Seda; Maartje Geerlings; Peggy Lim; Jeshmi Jeyabalan-Srikaran; Ann-Christin Cichon; Peter J Scambler; Philip L Beales; Victor Hernandez-Hernandez; Andrew W Stoker; Dagan Jenkins
Journal:  Mol Syndromol       Date:  2018-07-21

6.  Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient.

Authors:  Parvathy Venugopal; Sarah Moore; David M Lawrence; Amee J George; Ross D Hannan; Sarah Ce Bray; Luen Bik To; Richard J D'Andrea; Jinghua Feng; Amanda Tirimacco; Alexandra L Yeoman; Chun Chun Young; Miriam Fine; Andreas W Schreiber; Christopher N Hahn; Christopher Barnett; Ben Saxon; Hamish S Scott
Journal:  Haematologica       Date:  2017-09-29       Impact factor: 9.941

7.  RPL13 Variants Cause Spondyloepimetaphyseal Dysplasia with Severe Short Stature.

Authors:  Cedric Le Caignec; Benjamin Ory; François Lamoureux; Marie-Francoise O'Donohue; Emilien Orgebin; Pierre Lindenbaum; Stéphane Téletchéa; Manon Saby; Anna Hurst; Katherine Nelson; Shawn R Gilbert; Yael Wilnai; Leonid Zeitlin; Eitan Segev; Robel Tesfaye; Mathilde Nizon; Benjamin Cogne; Stéphane Bezieau; Loic Geoffroy; Antoine Hamel; Emmanuelle Mayrargue; Benoît de Courtivron; Aliette Decock-Giraudaud; Céline Charrier; Olivier Pichon; Christelle Retière; Richard Redon; Alexander Pepler; Kirsty McWalter; Lydie Da Costa; Annick Toutain; Pierre-Emmanuel Gleizes; Marc Baud'huin; Bertrand Isidor
Journal:  Am J Hum Genet       Date:  2019-10-17       Impact factor: 11.025

8.  tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.

Authors:  Kristin E N Watt; Cynthia L Neben; Shawn Hall; Amy E Merrill; Paul A Trainor
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

9.  Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.

Authors:  K Nicole Weaver; Kristin E Noack Watt; Robert B Hufnagel; Joaquin Navajas Acedo; Luke L Linscott; Kristen L Sund; Patricia L Bender; Rainer König; Charles M Lourenco; Ute Hehr; Robert J Hopkin; Dietmar R Lohmann; Paul A Trainor; Dagmar Wieczorek; Howard M Saal
Journal:  Am J Hum Genet       Date:  2015-04-23       Impact factor: 11.025

Review 10.  Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies.

Authors:  Michal Hetman; Lukasz P Slomnicki
Journal:  J Neurochem       Date:  2018-11-12       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.